Skip to main content
Prime Medicine, Inc. (PRME)
NASDAQ: PRME · Real-Time Price · USD
3.690
+0.020 (0.54%)
At close: Apr 28, 2026, 4:00 PM EDT
3.690
0.00 (0.01%)
After-hours: Apr 28, 2026, 7:55 PM EDT

Prime Medicine Revenue

In the year 2025, Prime Medicine had annual revenue of $4.63M with 55.28% growth. Prime Medicine had revenue of $838.00K in the quarter ending December 31, 2025, a decrease of -61.61%.

Revenue (ttm)
$4.63M
Revenue Growth
+55.28%
P/S Ratio
141.07
Revenue / Employee
$31,726
Employees
146
Market Cap
653.42M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20254.63M1.65M55.28%
Dec 31, 20242.98M--
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
CorMedix 311.71M
Arvinas 262.60M
Gyre Therapeutics 116.59M
Lexicon Pharmaceuticals 49.80M
Prothena Corporation 9.68M
Aclaris Therapeutics 7.83M
Shattuck Labs 1.00M
Revenue Rankings

PRME News

More News